Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000928475-09-000298
Filing Date
2009-05-26
Accepted
2009-05-26 17:18:34
Documents
1
Period of Report
2009-05-21

Document Format Files

Seq Description Document Type Size
1 form3052609_ex.html 3  
1 form3052609_ex.xml 3 1444
  Complete submission text file 0000928475-09-000298.txt   3530
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ICAHN CAPITAL LP 767 FIFTH AVENUE, SUITE 4700 NEW YORK NY 10153
Business Address
Denner Alexander J (Reporting) CIK: 0001361754 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-12957 | Film No.: 09852553